Syncardia Systems LLC-医療機器分野:企業M&A・提携分析

◆英語タイトル:Syncardia Systems LLC - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011965
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Syncardia Systems LLC (SynCardia), a subsidiary of Versa Capital Management, Inc. develops and manufactures artificial human heart. Its flagship product, SynCardia temporary Total Artificial Heart (TAH-t) temporarily takes up the complete function of a failed human heart in patients suffering from final stage biventricular heart failure (BHF) before receiving a successful heart transplant. The TAH-t replaces the ventricles and four heart valves of a failing heart and eliminates the symptoms and source of end-stage BHF. SynCardia also offers the Freedom portable external pneumatic drivers, which power TAH-t and facilitate the discharge of clinically stable patients from the hospital, while waiting for a matching donor heart. The company offers TAH-t through certified centers in various parts of Europe, North America and Asia-Pacific. The company operates through its subsidiary in Germany. SynCardia is headquartered in Tucson, Arizona, the US.

Syncardia Systems LLC – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Syncardia Systems LLC, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Syncardia Systems LLC, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Syncardia Systems LLC, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Syncardia Systems LLC, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Syncardia Systems LLC, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Syncardia Systems LLC, Medical Equipment, Deal Details 10
Asset Purchase 10
SynCardia Systems Acquires Assets Related to SPUS of World Heart 10
Venture Financing 11
SynCardia Systems Raises US$14 Million In Venture Financing 11
SynCardia Systems Raises US$1.4 Million In Venture Financing 12
Private Equity 13
Versa Capital Management Acquires SynCardia Systems 13
SynCardia Systems Raises US$19 Million In Private Equity Financing 14
Partnerships 15
SynCardia Systems Enters into Licensing Agreement with Medtronic 15
Equity Offering 16
SynCardia Systems Withdraws IPO for up to USD30 Million 16
SynCardia Systems Raises USD4.1 Million in Public Offering of Series F Preferred Stock 18
SynCardia Systems Raises USD6 Million in Private Placement of Series F Preferred Stock 19
Acquisition 20
SynCardia Systems up for Sale 20
Syncardia Systems LLC – Key Competitors 21
Syncardia Systems LLC – Key Employees 22
Syncardia Systems LLC – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Corporate Communications 24
Mar 14, 2017: SynCardia Names New VP of Manufacturing and Facilities 24
Product News 25
Mar 29, 2017: SynCardia to Honor Eight Leading Total Artificial Heart Hospitals during ISHLT 25
02/29/2016: Early Findings of the 50cc SynCardia Heart Indicate That It Fits Underserved Patients – Women & Adolescents 27
Other Significant Developments 28
Jun 21, 2017: Italian Boy Becomes Youngest Patient Bridged to Transplant with the SynCardia temporary Total Artificial Heart 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Syncardia Systems LLC, Medical Equipment, Key Facts 2
Syncardia Systems LLC, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Syncardia Systems LLC, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Syncardia Systems LLC, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Syncardia Systems LLC, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Syncardia Systems LLC, Deals By Market, 2011 to YTD 2017 8
Syncardia Systems LLC, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
SynCardia Systems Acquires Assets Related to SPUS of World Heart 10
SynCardia Systems Raises US$14 Million In Venture Financing 11
SynCardia Systems Raises US$1.4 Million In Venture Financing 12
Versa Capital Management Acquires SynCardia Systems 13
SynCardia Systems Raises US$19 Million In Private Equity Financing 14
SynCardia Systems Enters into Licensing Agreement with Medtronic 15
SynCardia Systems Withdraws IPO for up to USD30 Million 16
SynCardia Systems Raises USD4.1 Million in Public Offering of Series F Preferred Stock 18
SynCardia Systems Raises USD6 Million in Private Placement of Series F Preferred Stock 19
SynCardia Systems up for Sale 20
Syncardia Systems LLC, Key Competitors 21
Syncardia Systems LLC, Key Employees 22
Syncardia Systems LLC, Subsidiaries 23

★海外企業調査レポート[Syncardia Systems LLC-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Seacoast Banking Corporation of Florida:企業の戦略・SWOT・財務情報
    Seacoast Banking Corporation of Florida - Strategy, SWOT and Corporate Finance Report Summary Seacoast Banking Corporation of Florida - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Lahey Hospital and Medical Center:企業の戦略的SWOT分析
    Lahey Hospital and Medical Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Galapagos NV:企業のM&A・事業提携・投資動向
    Galapagos NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Galapagos NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Pier 1 Imports, Inc.:企業の戦略・SWOT・財務情報
    Pier 1 Imports, Inc. - Strategy, SWOT and Corporate Finance Report Summary Pier 1 Imports, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bechtel Corporation:電力:M&Aディール及び事業提携情報
    Summary Bechtel Corporation (Bechtel) is a provider of engineering, construction and project management services. It provides a diverse portfolio of services to energy, transportation, infrastructure, communications, mining and metals, oil and gas, chemicals, water, defense and nuclear, and governme …
  • Pharmaxis Ltd (PXS)-医療機器分野:企業M&A・提携分析
    Summary Pharmaxis Ltd (Pharmaxis) is a pharmaceutical research company that develops and commercialize healthcare products. The company offers products such as aridol which identify twitchy and assist in diagnosing and managing asthma, and bronchitol which restores normal lung hydration, improves lu …
  • Aalberts Industries NV:企業のM&A・事業提携・投資動向
    Aalberts Industries NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aalberts Industries NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Foundation Medicine, Inc.:企業のM&A・事業提携・投資動向
    Foundation Medicine, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Foundation Medicine, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Atrium Innovations Inc:企業の戦略的SWOT分析
    Atrium Innovations Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • British Business Bank Plc:企業の戦略的SWOT分析
    British Business Bank Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • NeuroMetrix Inc (NURO)-医療機器分野:企業M&A・提携分析
    Summary NeuroMetrix Inc (NeuroMetrix) is a medical device company that develops wearable medical technology and point of care test to manage chronic pain, nerve diseases, and sleep disorders. The company’s products include quell wearable pain relief device, SENSUS pain therapy device, NC-stat DPNChe …
  • Real Matters Inc (REAL):企業の財務・戦略的SWOT分析
    Real Matters Inc (REAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Galaxy Entertainment Group Ltd:企業の戦略・SWOT・財務分析
    Galaxy Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Galaxy Entertainment Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Nikkiso Co Ltd (6376):企業の製品パイプライン分析2018
    Summary Nikkiso Co., Ltd. (Nikkiso) is a diversified company that develops, manufactures and markets medical equipment and industrial instruments. The company’s product portfolio includes pumps, odorizing systems, metering and mixing systems, ceramic substrate production systems, water-conditioning …
  • Orchid Pharma Ltd (ORCHIDPHAR):企業の財務・戦略的SWOT分析
    Summary Orchid Pharma Ltd (Orchid), formerly Orchid Chemicals & Pharmaceuticals Ltd is a pharmaceutical company that develops and manufactures pharmaceutical solutions such as formulations and API products. The company offers formulations such as cardiovascular products, neuropsychiatry products, an …
  • Vitasoy International Holdings Ltd (0345):企業の財務・戦略的SWOT分析
    Vitasoy International Holdings Ltd (0345) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Murphy Oil Corp (MUR):企業の財務・戦略的SWOT分析
    Murphy Oil Corp (MUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Lycored Ltd:企業の戦略・SWOT・財務情報
    Lycored Ltd - Strategy, SWOT and Corporate Finance Report Summary Lycored Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Takashimaya Company, Limited:企業の戦略・SWOT・財務分析
    Takashimaya Company, Limited - Strategy, SWOT and Corporate Finance Report Summary Takashimaya Company, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Natera Inc (NTRA):企業の財務・戦略的SWOT分析
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, g …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆